Schedule 13G ownership disclosure
CASI PHARMACEUTICALS INC
Security class unavailable · CUSIP: G1933S101
Event date: 2024-07-15
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 9.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-24-082776
- Form type
- SC 13G
- Filer
- CASI Pharmaceuticals, Inc.
- CIK
- CIK 1962738
- Filed
- Jul 25, 2024
- Reporting period
- Jul 15, 2024
- Description
- Schedule 13G beneficial ownership